Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 NOK)

NET PROFIT (x1000 NOK)

EMPLOYEES

Share

Hansa Biopharma AB

Closing information (x1000 NOK)

Closing information 2024/12 2023/12 (consolidated) 2022/12 (consolidated)
Turnover 176,678 Less Arrow 135,841 More Arrow 146,167
Financial expenses 193,022 Less Arrow 106,895 Less Arrow 46,008
Earnings before taxes -954,743 More Arrow -841,639 More Arrow -576,987
EBITDA -641,211 Less Arrow -788,818 More Arrow -556,753
Total assets 2,127,150 Less Arrow 1,031,308 More Arrow 1,596,139
Current assets 581,485 More Arrow 866,295 More Arrow 1,517,910
Current liabilities 261,461 More Arrow 325,171 Less Arrow 250,396
Equity capital 695,559 Less Arrow -170,064 More Arrow 570,301
- share capital 69,936 Less Arrow 55,751 Less Arrow 52,057
Employees (average) 0 More Arrow 159 Less Arrow 144

Financial ratios

Fiscal year 2024/12 2023/12 (consolidated) 2022/12 (consolidated)
Solvency 32.7% Less Arrow -16.5% More Arrow 35.7%
Turnover per employee 854 More Arrow 1,015
Profit as a percentage of turnover -540.4% Less Arrow -619.6% More Arrow -394.7%
Return on assets (ROA) -35.8% Less Arrow -71.2% More Arrow -33.3%
Current ratio 222.4% More Arrow 266.4% More Arrow 606.2%
Return on equity (ROE) -137.3% More Arrow 494.9% Less Arrow -101.2%
Change turnover
Change turnover % -13% More Arrow 356%
Chg. No. of employees
Chg. No. of employees % 10% More Arrow 24%

Total value of public sale

Fiscal year 2024/12 2023/12 (consolidated) 2022/12 (consolidated)
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.